Support for use of MDMA in medical trials and treatment U.S. 2017

Percentage of U.S. adults who supported allowing researchers to conduct medical trials with MDMA as of 2017

Loading statistic...
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2017

Region

North America, United States

Survey time period

June 2 to 5, 2017

Number of respondents

1,125 respondents

Age group

18 years and older

Special properties

U.S. adults

Supplementary notes

Original question: In 2016, The FDA approved MDMA (also known as ecstasy) for Phase 3 clinical trials as a treatment for post-traumatic stress disorder (PTSD) — a final step before possible approval as a prescription drug. One study showed that with 3 doses of MDMA administered under a psychiatrist's guidance, the patients reported a 56% decrease of severity of symptoms on average. At the end of the study, 66% no longer met the criteria for having PTSD — improvements lasted more than a year after therapy. Do you support or oppose similar medical trials with MDMA being conducted in the future?

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Statistics on " Clinical trials "

Other statistics that may interest you Clinical trials

R&D overview

6

Top R&D companies

5

Clinical studies

7

Participation

4

Costs and market

6

Approvals, launches, setbacks

6

COVID-19

4

Further related statistics

10
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Learn more about how Statista can support your business.